The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
Subscribe To Our Newsletter & Stay Updated
